Ligand Pharmaceuticals Inc (LGND)
115.45
-6.63
(-5.43%)
USD |
NASDAQ |
Nov 14, 16:00
115.58
+0.13
(+0.11%)
After-Hours: 20:00
Ligand Pharmaceuticals Cash and Short Term Investments (Quarterly): 219.64M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 219.64M |
| June 30, 2024 | 226.93M |
| March 31, 2024 | 310.59M |
| December 31, 2023 | 170.31M |
| September 30, 2023 | 190.50M |
| June 30, 2023 | 219.04M |
| March 31, 2023 | 282.66M |
| December 31, 2022 | 211.87M |
| September 30, 2022 | 121.41M |
| June 30, 2022 | 147.94M |
| March 31, 2022 | 204.00M |
| December 31, 2021 | 341.11M |
| September 30, 2021 | 323.21M |
| June 30, 2021 | 301.84M |
| March 31, 2021 | 339.21M |
| December 31, 2020 | 411.19M |
| September 30, 2020 | 795.07M |
| June 30, 2020 | 809.88M |
| March 31, 2020 | 771.69M |
| December 31, 2019 | 1.070B |
| September 30, 2019 | 1.150B |
| June 30, 2019 | 1.392B |
| March 31, 2019 | 1.501B |
| December 31, 2018 | 773.83M |
| September 30, 2018 | 1.112B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.017B |
| March 31, 2018 | 291.89M |
| December 31, 2017 | 201.66M |
| September 30, 2017 | 202.26M |
| June 30, 2017 | 172.63M |
| March 31, 2017 | 159.37M |
| December 31, 2016 | 141.05M |
| September 30, 2016 | 124.12M |
| June 30, 2016 | 106.95M |
| March 31, 2016 | 113.20M |
| December 31, 2015 | 200.22M |
| September 30, 2015 | 187.30M |
| June 30, 2015 | 181.61M |
| March 31, 2015 | 177.22M |
| December 31, 2014 | 167.34M |
| September 30, 2014 | 186.59M |
| June 30, 2014 | 22.03M |
| March 31, 2014 | 25.25M |
| December 31, 2013 | 15.98M |
| September 30, 2013 | 3.271M |
| June 30, 2013 | 5.923M |
| March 31, 2013 | 5.037M |
| December 31, 2012 | 12.38M |
| September 30, 2012 | 7.046M |
| June 30, 2012 | 10.38M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
121.41M
Minimum
Sep 2022
1.070B
Maximum
Dec 2019
373.40M
Average
292.25M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 9.796B |
| Agios Pharmaceuticals Inc | 1.005B |
| ADMA Biologics Inc | 86.71M |
| Pieris Pharmaceuticals Inc | 19.73M |
| AnaptysBio Inc | 430.12M |